These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33426981)

  • 1. A Retrospective Comparison of the Effectiveness and Safety of Intravenous Olanzapine Versus Intravenous Haloperidol for Agitation in Adult Intensive Care Unit Patients.
    Wang M; Yankama TT; Abdallah GT; Eche IJ; Knoph KN; Wong A; Patel P; Hsu D; Eche IM
    J Intensive Care Med; 2022 Feb; 37(2):222-230. PubMed ID: 33426981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic Management of Intensive Care Unit Delirium: Clinical Prescribing Practices and Outcomes in More Than 8500 Patient Encounters.
    Boncyk CS; Farrin E; Stollings JL; Rumbaugh K; Wilson JE; Marshall M; Feng X; Shotwell MS; Pandharipande PP; Hughes CG
    Anesth Analg; 2021 Sep; 133(3):713-722. PubMed ID: 33433117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue Sedation When Treating Acute Agitation in the Emergency Department With Intramuscular Antipsychotics.
    Klein LR; Driver BE; Horton G; Scharber S; Martel ML; Cole JB
    J Emerg Med; 2019 May; 56(5):484-490. PubMed ID: 30745194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Effectiveness of Intravenous Chlorpromazine for Agitation in Critically Ill Patients.
    Choi M; Barra ME; Newman K; Sin JH
    J Intensive Care Med; 2020 Oct; 35(10):1118-1122. PubMed ID: 30558470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.
    Wright P; Meehan K; Birkett M; Lindborg SR; Taylor CC; Morris P; Breier A
    Clin Ther; 2003 May; 25(5):1420-8. PubMed ID: 12867218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study.
    Al-Qadheeb NS; Skrobik Y; Schumaker G; Pacheco MN; Roberts RJ; Ruthazer RR; Devlin JW
    Crit Care Med; 2016 Mar; 44(3):583-91. PubMed ID: 26540397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-Generation Parenteral Antipsychotic (Olanzapine) as a First-Line Treatment for Acute Undifferentiated Agitation in the Emergency Department in Comparison With Haloperidol.
    Singh AP; Murali Mohan NT
    Cureus; 2023 Jun; 15(6):e40226. PubMed ID: 37435257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study.
    Freeman DJ; DiPaula BA; Love RC
    Pharmacotherapy; 2009 Aug; 29(8):930-6. PubMed ID: 19637946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
    Isenberg DL; Jacobs D
    Prehosp Disaster Med; 2015 Oct; 30(5):491-5. PubMed ID: 26323511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department.
    Klein LR; Driver BE; Miner JR; Martel ML; Hessel M; Collins JD; Horton GB; Fagerstrom E; Satpathy R; Cole JB
    Ann Emerg Med; 2018 Oct; 72(4):374-385. PubMed ID: 29885904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Intravenous Olanzapine Administration at a Tertiary Academic Medical Center.
    Hunt NF; McLaughlin KC; Kovacevic MP; Lupi KE; Dube KM
    Ann Pharmacother; 2021 Sep; 55(9):1127-1133. PubMed ID: 33455436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral Antipsychotic Choice and Its Association With Emergency Department Length of Stay for Acute Agitation Secondary to Alcohol Intoxication.
    Cole JB; Klein LR; Martel ML
    Acad Emerg Med; 2019 Jan; 26(1):79-84. PubMed ID: 29851193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
    Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
    J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.
    MacDonald K; Wilson M; Minassian A; Vilke GM; Becker O; Tallian K; Cobb P; Perez R; Galangue B; Feifel D
    J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Large Retrospective Cohort of Patients Receiving Intravenous Olanzapine in the Emergency Department.
    Martel ML; Klein LR; Rivard RL; Cole JB
    Acad Emerg Med; 2016 Jan; 23(1):29-35. PubMed ID: 26720055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intramuscular haloperidol and other short-acting injectable antipsychotics for management of acute agitation in an adult inpatient psychiatry unit.
    Gamcsik S; Adams KS
    Ment Health Clin; 2024 Aug; 14(4):242-246. PubMed ID: 39104435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy for delirium in terminally ill adults.
    Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-Label Use of Intravenous Olanzapine for Agitation After Neurologic Injury.
    Tsai YV; Fawzy JH; Durkin JB; Then JE; McGinnis CB
    Hosp Pharm; 2021 Dec; 56(6):697-701. PubMed ID: 34732924
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-Effectiveness of Midazolam Versus Haloperidol Versus Olanzapine for the Management of Acute Agitation in the Accident and Emergency Department.
    Yan VKC; Haendler M; Lau H; Li X; Lao KSJ; Tsui SH; Yap CYL; Knapp MRJ; Chan EW
    Value Health; 2022 Jul; 25(7):1099-1106. PubMed ID: 35151559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
    Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
    Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.